Invitae Corporation
NVTA
Rangering i aksjer
#35800
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Aksjekurs
$0.016
Sist synkronisert: 2024-03-11
Markedsverdi
$3.27M
Endring (1 dag)
-5.33%
Endring (1 år)
3,100.00%
Land
US
Handel Invitae Corporation (NVTA)
Kategori
Healthcare
Markedsverdi av Invitae Corporation(NVTA)
Markedsverdi: $3.27M
Per October 2026 har Invitae Corporation en markedsverdi på $3.27M. Dette gjør Invitae Corporation til det 35800th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Invitae Corporation fra 2022 til 2026
NVTA sammenlignet med topp 5 mest populære stocks
| Pris på NVTA | Eiendel B | Markedsverdi for B | Resultater | |
|---|---|---|---|---|
$22,544.39
$114.60K
|
$5.167T | +4,508,878,840.98% | ||
|
$21,880.06
$114.60K
|
$5.015T | +4,376,012,501.29% | ||
|
$17,925.44
$114.60K
|
$4.108T | +3,585,086,967.85% | ||
|
$17,024.46
$114.60K
|
$3.902T | +3,404,891,614.88% | ||
|
$11,734.41
$114.60K
|
$2.689T | +2,346,881,617.67% |
